MRA 2018-2019 Request for Proposals

קרןMelanoma Research Alliance
מדינהU.S.A.
סוגResearch Grants
תאריך אחרון02/11/2018
פקולטהEngineering, Exact Sciences, Life Sciences, Medicine
תיאור

MRA is soliciting proposals that address the gap in translational science. For the 2018-2019 cycle, MRA seeks proposals in the following areas:

 

• Identifying strategies to overcome resistance, treatment failure, and/or difficult-to-treat melanoma subtypes such as acral, mucosal or uveal melanoma
• Informing logical and optimal combination therapies, therapeutic sequences, and/or treatment regimens including adjuvant and neoadjuvant approaches
• Developing strategies to prevent and/or treat metastatic disease
• Identifying markers of response, resistance, and/or risk of recurrence or death
• Improving prevention and early detection strategies by understanding of the biological basis for melanoma formation and/or developing new diagnostic approaches

 

Types of Awards: 

  1. Established Investigator Awards
  2. Pilot Award
  3. Young Investigator Award
  4. Special opportunity: MRA Young Investigator Award and Established Investigator Award for Artificial Intelligence Applied to Melanoma
  5. Special opportunity: MRA Young Investigator Award and Established in Dermatology
  6. Special opportunity: Bristol-Myers Squibb  and MRA Young Investigator Award in Immunotherapy 
  7. Special Opportunity: Society for Immunotherapy of Cancer and MRA Young Investigator Award in  Immune-Related Adverse Events Associated with Immunotherapy 

 

Young applicant should be less that 4 yeras from first independent faculty position. All young applicants must submit an eligibility checklist by Oct. 19, 2018

 

 

Funding:

Established: $125,000 per year 

Young: $75,000 per year 

Pilot: $50,000 per yer 

 

Duration:

pilot award: 2 years

Other: 3 years

 

קבצים מצורפים
קישורלאתר
עדכון אחרוןעדכון אחרון: 08/08/2018
אוניברסיטת תל אביב עושה כל מאמץ לכבד זכויות יוצרים. אם בבעלותך זכויות יוצרים בתכנים שנמצאים פה ו/או השימוש
שנעשה בתכנים אלה לדעתך מפר זכויות, נא לפנות בהקדם לכתובת שכאן >>